ChargePoint Technology Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ChargePoint Technology Limited - overview
Established
2009
Location
Liverpool, -, UK
Primary Industry
Pharmaceuticals
About
ChargePoint Technology Limited, based in the UK, specializes in advanced containment and aseptic processing solutions for the pharmaceutical and life sciences industries, ensuring product quality and sterility during critical operations. ChargePoint Technology Limited provides advanced containment solutions for the pharmaceutical sector, utilizing innovative technologies to enhance safety and efficiency. Founded in 2009 in Liverpool, UK, the company has undergone strategic developments, including its acquisition by Arcline Investment Management from LDC in March 2021, although financial terms were not disclosed. The company has secured funding through multiple rounds, with the latest raising GBP 1.
630 mn from investors including Mercia Asset Management and North West Business Finance, bringing its total funds raised to GBP 1. 630 mn. Chris Eccles serves as the CEO, leading the firm in its operational strategies. ChargePoint Technology specializes in advanced containment and aseptic processing solutions tailored for the pharmaceutical, biopharmaceutical, and life sciences sectors.
Their core products include the ChargePoint AseptiSafe® range of aseptic split butterfly valves, designed to enhance product quality and sterility assurance, and the ChargeBag® PE-S, which mitigates cross-contamination and eliminates extensive cleaning procedures. Additionally, the ChargePoint PharmaSafe® transfer valves ensure optimal operator protection through validated containment performance, catering to a diverse clientele across North America, Europe, and Asia. ChargePoint Technology operates on a business-to-business model, engaging primarily with pharmaceutical and biopharmaceutical companies. In 2023, the company reported a revenue of GBP 29,415,025.
60 and an EBITDA of GBP 11,967,382. 40. Revenue is generated through direct sales of their innovative products, such as the ChargeBag® and ChargePoint AseptiSafe® valves, complemented by ongoing support services and maintenance agreements. ChargePoint Technology aims to strengthen its global presence by enhancing localized services worldwide and accelerating its product development pipeline following its acquisition by Arcline Investment Management.
The company plans to introduce new products, though specific details have not been disclosed. ChargePoint Technology is actively targeting expansion into additional geographic markets, with a focus on increasing its footprint in North America and Asia by 2024, leveraging the recent GBP 1. 630 mn funding to support these initiatives.
Current Investors
Arcline Investment Management
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals, Industrial Machinery
Website
www.thechargepoint.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
ChargePoint Technology Limited - timeline of key events
ChargePoint Technology Limited - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Jan 07, 2019 | Jan 07, 2020 | Jan 07, 2021 | Jan 07, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 4,075,548 | 6,887,324 | 4,691,775 | 5,619,128 | 7,420,691 | 8,098,866 | 11,150,534 | 11,858,563 | - | 12,411,878 | 12,723,428 | 15,305,571 | - | - | - |
| % Revenue Growth (YoY) | - | 69.0% | (31.9%) | 19.8% | 32.1% | 9.1% | 37.7% | 6.3% | - | - | - | 20.3% | - | - | - |
| EBITDA (USD) | 696,889 | 1,224,148 | 553,587 | 1,184,357 | 1,566,224 | 2,300,366 | 3,884,912 | 3,109,690 | - | 4,208,857 | 4,605,778 | 5,469,396 | - | - | - |
| Operating Income (USD) | 635,121 | 981,357 | 199,973 | 790,074 | 1,195,143 | 1,821,079 | 3,349,895 | 2,358,052 | - | 3,207,652 | 3,324,895 | 3,926,882 | - | - | - |
| Operating Margin | 15.6% | 14.2% | 4.3% | 14.1% | 16.1% | 22.5% | 30.0% | 19.9% | - | 25.8% | 26.1% | 25.7% | - | - | - |
| % EBITDA Margin | 17.1% | 17.8% | 11.8% | 21.1% | 21.1% | 28.4% | 34.8% | 26.2% | - | 33.9% | 36.2% | 35.7% | - | - | - |
| NET Income (USD) | 547,111 | 901,365 | 269,301 | 761,085 | 1,167,961 | 1,859,986 | 2,704,060 | 2,850,715 | - | 3,456,959 | 2,982,438 | 3,865,389 | - | - | - |
| % Net Margin | 13.4% | 13.1% | 5.7% | 13.5% | 15.7% | 23.0% | 24.3% | 24.0% | - | 27.9% | 23.4% | 25.3% | - | - | - |
ChargePoint Technology Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Wang Engineering, Inc. | - | ||||||||
| Add-on | Completed | Terracon Consultants, Inc. | - | ||||||||
| Secondary Buyout | Completed | ChargePoint Technology Limited | - | ||||||||
| Secondary Buyout | Completed | ChargePoint Technology Limited | - |
Displaying 1 - 4 of 4
ChargePoint Technology Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.